2024 Q2 Form 10-Q Financial Statement

#000149315224018344 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue -$3.656M -$3.223M
YoY Change -3.93% -23.66%
Cost Of Revenue $1.214M $1.214M
YoY Change 0.0% 0.08%
Gross Profit -$186.9K $313.8K
YoY Change -218.34% 265.8%
Gross Profit Margin
Selling, General & Admin $3.006M $3.087M
YoY Change -8.55% -19.14%
% of Gross Profit 983.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.683M $4.751M
YoY Change -9.55% -13.94%
Operating Profit -$4.870M -$4.437M
YoY Change -2.98% -18.36%
Interest Expense -$6.996M $1.214M
YoY Change -676.11% 0.08%
% of Operating Profit
Other Income/Expense, Net $462.8K $449.6K
YoY Change -31.58% -8.17%
Pretax Income -$10.65M -$22.07M
YoY Change -31.81% -577.97%
Income Tax $52.79K $2.100K
% Of Pretax Income
Net Earnings -$10.65M -$22.07M
YoY Change -31.81% -577.97%
Net Earnings / Revenue
Basic Earnings Per Share -$0.45 -$0.87
Diluted Earnings Per Share -$0.45 -$0.87
COMMON SHARES
Basic Shares Outstanding 23.35M shares 25.35M shares
Diluted Shares Outstanding 23.41M shares 25.39M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.38M $50.81M
YoY Change 121.57% 5.61%
Cash & Equivalents $54.38M $50.81M
Short-Term Investments
Other Short-Term Assets $282.6K $467.2K
YoY Change -41.76% -28.59%
Inventory
Prepaid Expenses
Receivables $83.84K $137.7K
Other Receivables $71.05K $236.3K
Total Short-Term Assets $54.82M $51.66M
YoY Change 109.32% 4.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $182.9M $204.6M
YoY Change -22.56% -15.11%
Other Assets $561.1K $577.9K
YoY Change -4.97% 7.19%
Total Long-Term Assets $183.5M $205.2M
YoY Change -22.51% -15.06%
TOTAL ASSETS
Total Short-Term Assets $54.82M $51.66M
Total Long-Term Assets $183.5M $205.2M
Total Assets $238.3M $256.9M
YoY Change -9.38% -11.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.003M $1.271M
YoY Change -20.26% -46.83%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.047M $1.315M
YoY Change -24.16% -48.98%
LONG-TERM LIABILITIES
Long-Term Debt $73.92M $73.83M
YoY Change 0.49% 0.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $73.92M $73.83M
YoY Change 0.49% 0.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.047M $1.315M
Total Long-Term Liabilities $73.92M $73.83M
Total Liabilities $75.97M $75.15M
YoY Change -0.38% -1.19%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $233.8K $253.5K
YoY Change -7.96% -10.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $162.3M $181.7M
YoY Change
Total Liabilities & Shareholders Equity $238.3M $256.9M
YoY Change -9.38% -11.76%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$10.65M -$22.07M
YoY Change -31.81% -577.97%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $12.97M $22.74M
YoY Change -228.74% 180.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $107.8K
YoY Change 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.400M -$107.8K
YoY Change -30.37% 0.0%
NET CHANGE
Cash From Operating Activities 12.97M $22.74M
Cash From Investing Activities
Cash From Financing Activities -9.400M -$107.8K
Net Change In Cash 3.565M $22.64M
YoY Change -115.13% 183.09%
FREE CASH FLOW
Cash From Operating Activities $12.97M $22.74M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
467149 usd
CY2024Q1 SSSS Increase Decrease In Escrow Proceeds Receivable
IncreaseDecreaseInEscrowProceedsReceivable
-72990 usd
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001509470
CY2023 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-12-30
CY2024Q1 SSSS Purchases Of Us Treasury Bills Investments
PurchasesOfUSTreasuryBillsInvestments
usd
CY2023 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-12-30
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 SSSS Investments In U.S.Treasury Bills Cost
InvestmentsInU.s.TreasuryBillsCost
29621913 usd
CY2023Q4 SSSS Investments In U.S.Treasury Bills Cost
InvestmentsInU.s.TreasuryBillsCost
63810855 usd
CY2024Q1 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
236303 usd
CY2024Q1 SSSS Interest And Dividends Receivable
InterestAndDividendsReceivable
137657 usd
CY2024Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
577900 usd
CY2024Q1 us-gaap Assets
Assets
256870892 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1270583 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
44700 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
73834474 usd
CY2024Q1 us-gaap Liabilities
Liabilities
75149757 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
181721135 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25353284 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25353284 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25445805 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25445805 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
253533 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
248883867 usd
CY2024Q1 SSSS Accumulated Net Investment Loss
AccumulatedNetInvestmentLoss
-7527013 usd
CY2024Q1 SSSS Accumulated Net Realized Gain On Investments Net Of Distributions
AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions
-12772846 usd
CY2024Q1 SSSS Accumulated Net Unrealized Depreciation Appreciation Of Investments
AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments
-47116406 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
181721135 usd
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.17
CY2024Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0600 pure
CY2024Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-12-30
CY2024Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0600 pure
CY2024Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0653 pure
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
75000000 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0653 pure
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
75000000 usd
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1528091 usd
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1299082 usd
CY2024Q1 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
2185318 usd
CY2023Q1 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
2136754 usd
CY2024Q1 SSSS Directors Fees
DirectorsFees
171113 usd
CY2023Q1 SSSS Directors Fees
DirectorsFees
160565 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4616509 usd
CY2024Q1 SSSS Realized Investment Gain Losses
RealizedInvestmentGainLosses
-424074 usd
CY2023Q1 SSSS Realized Investment Gain Losses
RealizedInvestmentGainLosses
189343 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-18418370 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8648931 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
728559 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
990834 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1214267 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1213286 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
529780 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
449636 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
489628 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4750993 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
5520847 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
-3222902 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
-4221765 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-424074 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
189343 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-18418370 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8648931 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-22065346 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4616509 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25393490 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28378529 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25393490 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28378529 shares
CY2023Q4 us-gaap Assets Net
AssetsNet
203357646 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
210020702 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
-3222902 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
-4221765 usd
CY2024Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-424074 usd
CY2023Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
189343 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-18418370 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8648931 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-22065346 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4616509 usd
CY2024Q1 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
428835 usd
CY2023Q1 SSSS Stock Issued During Period Values Share Based Compensation Gross
StockIssuedDuringPeriodValuesShareBasedCompensationGross
405858 usd
CY2024Q1 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
428835 usd
CY2023Q1 SSSS Investment Company Capital Share Transactions
InvestmentCompanyCapitalShareTransactions
405858 usd
CY2024Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-21636511 usd
CY2023Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
5022367 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
181721135 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
215043069 usd
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
25445805 shares
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
28429499 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
92521 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
90919 shares
CY2024Q1 us-gaap Shares Outstanding
SharesOutstanding
25353284 shares
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
28338580 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-22065346 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
106093 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
104936 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
428835 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
405858 usd
CY2024Q1 SSSS Adjustments To Escrow Proceeds Receivable
AdjustmentsToEscrowProceedsReceivable
-72997 usd
CY2023Q1 SSSS Adjustments To Escrow Proceeds Receivable
AdjustmentsToEscrowProceedsReceivable
108394 usd
CY2024Q1 SSSS Accrued Interest On Us Treasury Bills
AccruedInterestOnUSTreasuryBills
376834 usd
CY2023Q1 SSSS Accrued Interest On Us Treasury Bills
AccruedInterestOnUSTreasuryBills
458580 usd
CY2024Q1 SSSS Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
10003934 usd
CY2023Q1 SSSS Purchases Of Portfolio Investments
PurchasesOfPortfolioInvestments
2003698 usd
CY2023Q1 SSSS Purchases Of Us Treasury Bills Investments
PurchasesOfUSTreasuryBillsInvestments
35497676 usd
CY2024Q1 SSSS Proceeds From Sales Or Maturity Of Investments Portfolio Investments
ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments
318316 usd
CY2023Q1 SSSS Proceeds From Sales Or Maturity Of Investments Portfolio Investments
ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments
2860159 usd
CY2024Q1 SSSS Proceeds From Sales Or Maturity Of Investments Us Treasury Bills
ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills
34547625 usd
CY2023Q1 SSSS Proceeds From Sales Or Maturity Of Investments Us Treasury Bills
ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills
45000118 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27453 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-72804 usd
CY2024Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
5050 usd
CY2023Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
-33758 usd
CY2023Q1 SSSS Increase Decrease In Escrow Proceeds Receivable
IncreaseDecreaseInEscrowProceedsReceivable
-18647 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
924275 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1680946 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22743870 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8103901 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
107823 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
107823 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-107823 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-107823 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22636047 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7996078 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28178352 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40117598 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50814399 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48113676 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1125000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1125000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2100 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4314 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80B_eus-gaap--NatureOfOperations_z7KkadUHRed8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_82A_zjoMCdLFCHA2">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Corp. (“we”, “us”, “our”, the “Company” or “SuRo Capital”), formerly known as Sutter Rock Capital Corp. and as GSV Capital Corp. and formed in September 2010 as a Maryland corporation, is an internally managed, non-diversified closed-end management investment company. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s date of inception was January 6, 2011, which is the date it commenced development stage activities. The Company’s common stock is currently listed on the Nasdaq Global Select Market under the symbol “SSSS” (formerly “GSVC”). Prior to November 24, 2021, the Company’s common stock traded on the Nasdaq Capital Market under the same symbol (“SSSS”). The Company began its investment operations during the second quarter of 2011.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below displays the Company’s subsidiaries as of March 31, 2024, which, other than GSV Capital Lending, LLC (“GCL”) and SuRo Capital Sports, LLC, are collectively referred to as the “Taxable Subsidiaries.” The Taxable Subsidiaries were formed to hold certain portfolio investments. The Taxable Subsidiaries, including their associated portfolio investments, are consolidated with the Company for accounting purposes, but have elected to be treated as separate entities for U.S. federal income tax purposes. GCL was formed to originate portfolio loan investments within the state of California and is consolidated with the Company for accounting purposes. Refer to “Note 2—Significant Accounting Policies—<i>Basis of Consolidation</i>” below for further detail.</span></p> <p id="xdx_896_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zKrlc3YJyeW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BC_zl9IuryViyE4" style="display: none">SCHEDULE OF COMPANY’S SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Subsidiary</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Formation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%">GCL</td><td style="width: 2%"> </td> <td style="width: 16%; text-align: center"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_z6V3tZtpX6T2" title="Jurisdiction of Incorporation">Delaware</span></td><td style="width: 2%"> </td> <td id="xdx_985_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zwBGSv7wnLHa" style="width: 16%; text-align: center" title="Formation Date">April 13, 2012</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zHulq8lcFoOk" style="width: 12%; text-align: right" title="Percentage Owned">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SuRo Capital Sports, LLC (“SuRo Sports”)</td><td> </td> <td style="text-align: center"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zFHwXWnsMjhk" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_982_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zrqvBID0Oapk" style="text-align: center" title="Formation Date">March 19, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zb88gpTjSobj" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Subsidiaries below are referred to collectively as the “Taxable Subsidiaries”</td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC AE Holdings, Inc. (“GAE”)</td><td> </td> <td style="text-align: center"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember_zPs5PSCiN8sl" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_985_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z4lbm9qIOa91" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zSETRowekpHg" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC AV Holdings, Inc. (“GAV”)</td><td> </td> <td style="text-align: center"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember_zVfJmiAyhtj9" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_98A_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zDJTK6hoJ6Oi" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zKSwLBDqxoGh" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC SW Holdings, Inc. (“GSW”)</td><td> </td> <td style="text-align: center"><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember_zJZugGOs44hi" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_983_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zfzxJTcTd7Rf" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zRxel5wuGpQi" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC SVDS Holdings, Inc. (“SVDS”)</td><td> </td> <td style="text-align: center"><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20240101__20240331__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember_zkcI5zJn6KH4" title="Jurisdiction of Incorporation">Delaware</span></td><td> </td> <td id="xdx_98C_edei--EntityIncorporationDateOfIncorporation_c20240101__20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z1thruqu2o7j" style="text-align: center" title="Formation Date">August 13, 2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zewylIcgG2Mj" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A7_zeBQDWwMCCh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on its equity and equity-related investments, and to a lesser extent, income from debt investments. The Company invests principally in the equity securities of what it believes to be rapidly growing venture capital-backed emerging companies. The Company may invest in these portfolio companies through offerings of the prospective portfolio companies, transactions on secondary marketplaces for private companies, or negotiations with selling stockholders. In addition, the Company may invest in private credit and in founders equity, founders warrants, forward purchase agreements, and private investment in public equity transactions of special purpose acquisition companies (“SPACs”). The Company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-U.S. companies that otherwise meet its investment criteria, subject to any applicable limitations under the 1940 Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SURO CAPITAL CORP. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1165526 usd
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1254793 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z4qOv6yrbxZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_z2B4Rd1btCyk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of Condensed Consolidated Financial Statements in accordance with GAAP requires the Company’s management to make a number of significant estimates. These include estimates of the fair value of certain assets and liabilities and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of certain revenues and expenses during the reporting period. It is likely that changes in these estimates may occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ materially from such estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q1 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
236303 usd
CY2023Q4 SSSS Escrow Proceeds Receivable
EscrowProceedsReceivable
309293 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0600 pure
CY2024Q1 SSSS Description For Deferred Financing Costs
DescriptionForDeferredFinancingCosts
The Company records fees and expenses incurred in connection with its 6.00% Notes due 2026 as deferred debt issuance costs. Such costs are reflected in the carrying value of the 6.00% Notes due 2026, and not the Company’s deferred financing costs
CY2024Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
577900 usd
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
594726 usd
CY2024Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
577900 usd
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
594726 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1743426 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1849519 usd
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
0 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
0 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
168568251 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
168568251 usd
CY2023 SSSS Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci
FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci
3136307 usd
CY2024Q1 SSSS Number Of Positions
NumberOfPositions
63
CY2024Q1 SSSS Number Of Portfolio Companies
NumberOfPortfolioCompanies
38
CY2023Q4 SSSS Number Of Positions
NumberOfPositions
63
CY2023Q4 SSSS Number Of Portfolio Companies
NumberOfPortfolioCompanies
38
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
175015571 usd
CY2024Q1 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.963 pure
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
184081249 usd
CY2023Q4 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.906 pure
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
175015571 usd
CY2024Q1 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2024Q1 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.963 pure
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
184081249 usd
CY2023Q4 SSSS Investment Owned Percent Of Investment Portfolio
InvestmentOwnedPercentOfInvestmentPortfolio
1.000 pure
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.906 pure
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
204637484 usd
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
247892104 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
168568251 usd
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
10003934 usd
CY2024Q1 SSSS Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss
-16738799 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
161833386 usd
CY2024Q1 SSSS Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci
FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci
-16738799 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
143865093 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
143865093 usd
CY2023 SSSS Transfers
Transfers
-2711842 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
24485430 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
-1374302 usd
CY2023 SSSS Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions
30820 usd
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-9815023 usd
CY2023 SSSS Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss
14088075 usd
CY2023Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
60000000.0 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-22065346 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4616509 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25393490 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28378529 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2024Q1 SSSS Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
-22065346 usd
CY2023Q1 SSSS Income Loss From Continuing Operations Diluted
IncomeLossFromContinuingOperationsDiluted
4616509 usd
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25393490 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28378529 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
64449 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
112485 usd
CY2024Q1 us-gaap Security Deposit
SecurityDeposit
16574 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
16574 usd
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
52662 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
48723 usd
CY2024Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P0Y3M18D
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0300 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
65330 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
65330 usd
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.99
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.39
CY2024Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.13
CY2023Q1 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.15
CY2024Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.02
CY2023Q1 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.01
CY2024Q1 SSSS Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
-0.73
CY2023Q1 SSSS Investment Company Unrealized Investment Income Loss From Operations Per Share
InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare
0.30
CY2024Q1 SSSS Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
0.06
CY2023Q1 SSSS Investment Company Share Based Compensation Arrangement By Share Based Payment
InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment
0.04
CY2024Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.17
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.59
CY2024Q1 SSSS Market Value Value Per Share
MarketValueValuePerShare
4.55
CY2023Q1 SSSS Market Value Value Per Share
MarketValueValuePerShare
3.62
CY2024Q1 SSSS Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
0.1548 pure
CY2023Q1 SSSS Investment Company Total Return Basedon Market Value
InvestmentCompanyTotalReturnBasedonMarketValue
-0.0474 pure
CY2024Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1026 pure
CY2023Q1 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0271 pure
CY2024Q1 us-gaap Shares Outstanding
SharesOutstanding
25353284 shares
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
28338580 shares
CY2024Q1 us-gaap Assets Net
AssetsNet
181721135 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
215043069 usd
CY2024Q1 SSSS Average Net Asset
AverageNetAsset
202519594 usd
CY2023Q1 SSSS Average Net Asset
AverageNetAsset
209347362 usd
CY2024Q1 us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.0944 pure
CY2023Q1 us-gaap Investment Company Expense Ratio After Incentive Allocation
InvestmentCompanyExpenseRatioAfterIncentiveAllocation
0.1070 pure
CY2024Q1 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
-0.0640 pure
CY2023Q1 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
-0.0818 pure
CY2024Q1 SSSS Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
0.0018 pure
CY2023Q1 SSSS Investment Company Turnover Ratio After Incentive Allocation
InvestmentCompanyTurnoverRatioAfterIncentiveAllocation
0.0124 pure
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.04 pure
CY2024Q1 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
(1) 98% of its ordinary income (taking into account certain deferrals and elections) for each calendar year, (2) 98.2% of its capital gain net income (adjusted for certain ordinary losses) for the 1-year period ending October 31 of each such calendar year and (3) any ordinary income and net capital gains for preceding years, but not distributed during such years and on which the Company paid no U.S. federal income tax.
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.04 pure
CY2024Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1165526 usd
CY2023Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1254793 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
ssss-20240331_cal.xml Edgar Link unprocessable
0001493152-24-018344-index-headers.html Edgar Link pending
0001493152-24-018344-index.html Edgar Link pending
0001493152-24-018344.txt Edgar Link pending
0001493152-24-018344-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssss-20240331.xsd Edgar Link pending
ssss-20240331_def.xml Edgar Link unprocessable
ssss-20240331_lab.xml Edgar Link unprocessable
ssss-20240331_pre.xml Edgar Link unprocessable